SCHEMBL29497740

SCHEMBL29497740

COc1c(O)c2c(c(O)c1C(C)C)C(=O)C(=O)[C@H]1C(C)(C)CCC[C@]21CO

nearest known ligand 0.36

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
▸ FDPS P14324 2/20 0.36
▸ EP300 Q09472 1/20 0.31
▸ GGPS1 O95749 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14542274 0.81 FDPS (0.43) FDPSGGPS1
Taiwaniaquinol B SCHEMBL31237215 0.78 USP2 (0.37) FDPSEP300GGPS1
Taiwaniaquinol E SCHEMBL31237185 0.78 USP2 (0.37) FDPSEP300GGPS1
Taiwaniaquinol B SCHEMBL18105238 0.78 USP2 (0.37) FDPSEP300GGPS1
SCHEMBL21291508 0.72 EP300 (0.40) FDPSEP300GGPS1
SCHEMBL22861906 0.72 EP300 (0.40) FDPSEP300GGPS1
SCHEMBL22862032 0.72 EP300 (0.40) FDPSEP300GGPS1
SCHEMBL21291523 0.72 EP300 (0.40) FDPSEP300GGPS1
SCHEMBL22861879 0.68 EP300 (0.35) FDPSEP300
SCHEMBL30190196 0.68 EP300 (0.35) FDPSEP300

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260130390-A1 USE OF PROTEOLYTIC ENZYMES TO ENHANCE PROTEIN BIOAVAILABILITY THE REGENTS OF THE UNIV OF CALIFORNIA (US) 2026-05-14 — — US disclosed
EP-3920708-B1 IMAGING BASED PORTION CUTTING MAREL SALMON AS (DK) 2026-04-15 — — EP disclosed
US-12465952-B2 Food processing device MAREL SALMON A/S (DK) 2025-11-11 — — US disclosed
US-12415969-B2 Fish oil recovery from aquatic biomass AQUAFOOD AB (SE) 2025-09-16 — — US disclosed
CN-113767174-B Methods for detection and enumeration of low concentration listeria 森西利斯特股份有限公司 2025-06-24 — — CN disclosed
CN-120192933-A Salmonella phage and composition and application thereof 创噬纪(上海)生物技术有限公司 2025-06-24 — — CN disclosed
US-20250194615-A1 Processing of Fish Products PureCut Technologies AS (NO) 2025-06-19 — — US disclosed
EP-4551012-A1 PLANT FOR AQUACULTURE AND OUTLET FOR AQUACULTURE TANKS AND OTHER USES THEREOF Bue Salmon AS (NO) 2025-05-14 — — EP disclosed
EP-4486887-A1 DETERMINATION AND QUANTIFICATION OF THE MICROBIAL COMMUNITIES AND ANTIMICROBIAL RESISTANCE GENES ON FOOD Quadram Institute Bioscience (GB) 2025-01-08 — — EP disclosed
EP-4486130-A1 PROCESSING OF FISH PRODUCTS Purecut Technologies AS (NO) 2025-01-08 — — EP disclosed
CN-115812661-A Sunlight industrial circulating water fish culture system and method 青海光子生态有限公司 2023-03-21 — — CN disclosed
US-20220401668-A1 Automatic System and Method for Injecting a Substance into an Animal APPLIED LIFESCIENCES AND SYSTEMS LLC (US) 2022-12-22 — — US disclosed
EP-2531038-B2 FOOD PROCESSING APPARATUS FOR DETECTING AND CUTTING TOUGH TISSUES FROM FOOD ITEMS VALKA EHF (IS) 2022-09-28 — — EP disclosed
CN-115032405-A Antigens of fish allergy 朋友股份有限公司 2022-09-09 — — CN disclosed
EP-4041852-A1 FISH OIL RECOVERY FROM AQUATIC BIOMASS Aquafood AB (SE) 2022-08-17 — — EP disclosed
CN-109313182-B Antigens of fish allergy 朋友股份有限公司 2022-07-01 — — CN disclosed
US-20220177945-A1 METHOD FOR DETECTING AND ENUMERATING OF LOW CONCENTRATIONS OF LISTERIA Sensilist AS (NO) 2022-06-09 — — US disclosed
CN-113588328-B Micro-sampling method for micro-chemical analysis of otolith 中国水产科学研究院黑龙江水产研究所 2022-04-19 — — CN disclosed
WO-2022075853-A1 GENERATING THREE-DIMENSIONAL SKELETON REPRESENTATIONS OF AQUATIC ANIMALS USING MACHINE LEARNING FISHENCY INNOVATION AS (NO) 2022-04-14 — — WO disclosed
US-20220095631-A1 IMAGING BASED PORTION CUTTING MAREL SALMON A/S (DK) 2022-03-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260130390-A1 USE OF PROTEOLYTIC ENZYMES TO ENHANCE PROTEIN BIOAVAILABILITY ALPI, FABP2, SI FDPS 2997/4885EP300 4821/4885GGPS1 4285/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback